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Abstract Adenosine modulates a wide variety of biologi-
cal processes via adenosine receptors. In the exocrine pan-
creas, adenosine regulates transepithelial anion secretion in
duct cells and is considered to play a role in acini-to-duct
signaling. To identify the functional adenosine receptors
and Cl− channels important for anion secretion, we herein
performed experiments on Capan-1, a human pancreatic
duct cell line, using open-circuit Ussing chamber and
gramicidin-perforated patch-clamp techniques. The luminal
addition of adenosine increased the negative transepithelial
potential difference (Vte) in Capan-1 monolayers with a half-
maximal effective concentration value of approximately
10 μM, which corresponded to the value obtained on whole-
cell Cl− currents in Capan-1 single cells. The effects of aden-
osine on Vte, an equivalent short-circuit current (Isc), and
whole-cell Cl− currents were inhibited by CFTRinh-172, a
cystic fibrosis transmembrane conductance regulator (CFTR)
Cl− channel inhibitor. The adenosine A2B receptor agonist,
BAY 60-6583, increased Isc and whole-cell Cl
− currents
through CFTR Cl− channels, whereas the A2A receptor ago-
nist, CGS 21680, had negligible effects. The A2B receptor
antagonist, PSB 603, inhibited the response of Isc to
adenosine. Immunohistochemical analysis showed that the
A2A and A2B receptors colocalized with Ezrin in the lumi-
nal membranes of Capan-1 monolayers and in rat pancre-
atic ducts. Adenosine elicited the whole-cell Cl− currents
in guinea pig duct cells. These results demonstrate that
luminal adenosine regulates anion secretion by activating
CFTR Cl− channels via adenosine A2B receptors on the
luminal membranes of Capan-1 cells. The present study
endorses that purinergic signaling is important in the reg-
ulation of pancreatic secretion.
Keywords Adenosine receptor . CFTR . Cl− channel . Duct .
Pancreas
Introduction
The pancreas plays a pivotal role in digestion. Pancreatic acini
secrete digestive enzymes, and ducts secrete a HCO3
−-rich
pancreatic juice that neutralizes acid chyme in the duodenum.
The generally accepted model for HCO3
− transport involves
Cl−–HCO3
− exchangers that operate in parallel with cAMP-
activated Cl− channels [cystic fibrosis transmembrane con-
ductance regulator (CFTR)] and Ca2+-activated Cl− channels,
such as TMEM16A/ANO1, on the luminal membranes of
duct cells [46, 50].
Extracellular adenosine has been shown tomodulate a wide
variety of biological processes via cell surface adenosine re-
ceptors [6, 10]. There are four known adenosine receptors
denoted adenosine A1, A2A, A2B, and A3 receptors. A2A and
A2B receptors generally increase, whereas A1 and A3 receptors
decrease cAMP levels [11]. Previous studies reported that
adenosine activated A1, A2A, A2B, and A3 receptors with
half-maximal effective concentration (EC50) values of 0.1,
0.3, 15, and 0.3 μM, respectively [10].
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In pancreatic ducts, adenosine is produced by the hydroly-
sis of ATP, which is secreted from acini in response to cholin-
ergic and hormonal stimuli [15, 16, 39, 52]. Previous studies
by Novak and coworkers have demonstrated that adenosine
activates Cl− conductance in rat pancreatic duct cells and in-
duce Cl− efflux in a human duct cell line (PANC-1) using a
patch-clamp analysis and Cl−-sensitive fluorophore, respec-
tively [32]. In addition, adenosine induced anion secretion
that was larger on the luminal side compared to the
basolateral side in a human pancreatic duct cell line
(Capan-1) monolayer [47]. Rat pancreatic ducts and human
duct cell lines (PANC-1 and CFPAC-1) were found to ex-
press adenosine A1, A2A, A2B, and A3 receptors, with the
adenosine A2A and A2B receptors being the most abundant
at the messenger RNA (mRNA) level [32]. Furthermore,
adenosine A2A receptors were detected on the luminal
membranes of rat ducts and plasma membrane of PANC-
1 cells [32]. Therefore, adenosine and ATP are regarded as
acini-to-duct messengers that stimulate ductal secretion
[32, 38]. However, the molecular basis of functional aden-
osine receptors and the intracellular mechanism of ductal
secretion via adenosine remain inconclusive.
The aim of the present study was to identify functional
adenosine receptors and Cl− channels using pharmacolog-
ical and electrophysiological tools. Capan-1 cells have
been shown to conserve most of the properties of duct
cells, including the functional expression of CFTR Cl−
channels and Ca2+-activated Cl− channels, and are, thus,
widely used as an epithelial model of human pancreatic
ducts [7, 18, 24, 25, 31, 44–47]. ATP and UTP were shown
to regulate CFTR Cl− channels, Ca2+-activated Cl− chan-
nels (TMEM16A/ANO1), and Ca2+-activated K+ channels
(KCa3.1) via purinergic receptors [18, 46]. In the present
study, we demonstrate that luminal adenosine regulates
transepithelial anion secretion by activating CFTR Cl−
channels via adenosine A2B receptors on the luminal mem-
branes of Capan-1 cells. Furthermore, we show that lumi-
nal adenosine activates Cl− conductance in native duct
cells from guinea pig.
Methods
Cell culture
Capan-1 cells were grown to confluent monolayers and
mounted in Ussing chambers for open-circuit recordings,
as described in detail previously [47]. Briefly, Capan-1
cells (#HTB-79; ATCC) were grown in Iscove’s modified
Dulbecco’s medium with Glutamax and 20 % FBS (Gibco)
[26]. Regarding Ussing chamber studies, cells were grown
on membranes (Snapwell, Costar 3801; Corning) in 37 °C
and 5 % CO2 for 7–28 days until confluent monolayers
were formed. Cells from passages 23 to 30 were used in
this study.
Open-circuit Ussing chamber measurements
Capan-1 monolayers were mounted in mini-Ussing chambers
(model P2300, Easymount Chamber System; Physiologic
Instruments) and electrophysiological parameters were re-
corded, as described in detail previously [22, 47]. Briefly,
the luminal and basolateral compartments were filled with a
solution containing the following (in mM): 115 NaCl, 5 KCl,
1 CaCl2, 1 MgCl2, 25 NaHCO3, 10 HEPES (pH 7.4, adjusted
with NaOH), and 10 D-glucose. The solution was equilibrated
with 5 % CO2 in O2. The temperature was kept constant at
37 °C during all experiments. The transepithelial potential
difference (Vte) was monitored using 3 M KCl/agar and Ag/
AgCl cartridge electrodes connected to a current-clamp am-
plifier (CEZ-9100; Nihon Kohden). Current pulses of 18 μA/
cm2 were applied at 5-s intervals, and transepithelial resistance
(Rte) was calculated. The equivalent short-circuit current (Isc)
was calculated from the Vte and Rte values. Vte is expressed as
luminal with respect to basolateral side. Isc is referred to as
positive for current flowing across the epithelium from lumi-
nal to basolateral side. Data were transferred to digital signals
through PowerLab 16/30 and were recorded using Chart 7
(ADInstruments).
Adenosine was obtained from Sigma-Aldrich. 4-[[4-Oxo-
2 - t h i o x o - 3 - [ 3 - t r i f l u o r o m e t h y l ) p h e n y l ] - 5 -
thiazolidinylidene]methyl]benzoic acid (CFTRinh-172),
niflumic acid, 5-nitro-2-(3-phenylpropylamino)benzoic acid
(NPPB), and 2-[(5-ethyl-1,6-dihydro-4-methyl-6-oxo-2-
py r im i d i ny l ) t h i o ] -N - [ 4 - ( 4 -me t hoxypheny l ) - 2 -
thiazolyl]acetamide (T16Ainh-A01) were obtained from
Santa Cruz Biotechnology, Cayman Chemical, Enzo Life
Sciences, and Merck Millipore, respectively. 2-[6-Amino-3,
5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-
ylsulfanyl]acetamide (BAY 60-6583), 4-[2-[[6-Amino-9-(N-
e thy l -β -D- r ibo fu ranuronamidosy l ) -9H-pur in -2 -
yl]amino]ethyl]benzenepropanoic acid (CGS 21680), and
8-[4-[4-(4-chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-
propylxanthine (PSB 603) were obtained from Tocris
Bioscience.
Patch-clamp whole-cell recording
Gramicidin-perforated patch techniques were used [19].
Gramicidin D (Sigma-Aldrich) was dissolved in DMSO at
20 mg/ml and then diluted to a final concentration of
0.1 mg/ml in a standard KCl-rich pipette solution containing
the following (in mM): 150 KCl and 10 HEPES; pH was
adjusted to 7.4 with KOH. The pipette tip was filled with the
gramicidin-free pipette solution by a brief immersion. The
pipette was then back-filled with the gramicidin-containing
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pipette solution. Patch pipettes (G-1.5; Narishige) had a resis-
tance of 3–4 MΩ when filled with the pipette solution. A
standard bathing solution contained the following (in mM):
150 NaCl, 1 CaCl2, and 5 HEPES; pH was adjusted to 7.4
with NaOH. The membrane potential was corrected for the
liquid junction potential at the tip of the patch pipette in the
bathing solution and for that at the tip of the indifferent refer-
ence electrode filled with bathing solution and placed in the
bath. Experiments were conducted at 23–30 °C. The whole-
cell current was recorded using the EPC 800 patch-clamp
amplifier (HEKA). The amplifier was driven by Clampex 9
(Axon) in order to allow the delivery of a voltage-ramp pro-
tocol with concomitant digitization of the current. Gramicidin-
perforated patch recording was started after stabilization of the
capacitive current. The capacitance transient current was com-
pensated by the amplifier. Whole-cell capacitance and series
resistance (Rs) were 13.5±0.9 pF and 47.8±4.5 MΩ (n=28),
respectively, in experiments using Capan-1 single cells. Since
Rs was not electronically compensated for, the conductance of
currents was underestimated as a result of the voltage decrease
across Rs, and the potential reported here was not corrected for
Rs. The voltage decrease was at most 20 mV. The whole-cell
current was filtered at 1 kHz with an internal four-pole Bessel
filter, sampled at 2 kHz, and transferred to digital signals
through Digidata 1322A (Axon). A subsequent current anal-
ysis was performed using Clampfit 9 (Axon).
Immunolocalization
Immunolocalization was performed on Capan-1 monolayers
and the rat pancreas. The pancreas was obtained from male
Wistar rats (n=3). Protocols involving the handling of ani-
mals were approved by the Animal Experimentation
Committee, Kansai Medical University. Animals were killed
by cervical dislocation. Detailed methods for immunohisto-
chemistry are described elsewhere [18]. Briefly, the rat pan-
creas was cut into small pieces and fixed with 4 % parafor-
maldehyde in PBS for 24 h. A confluent Capan-1 monolayer
was fixed with 4 % paraformaldehyde for 15 min and perme-
abilized with 0.2 % Triton X-100 in PBS for 10 min.
Autofluorescence was blocked in 0.1 M Tris-glycine.
Nonspecific binding was blocked with 2 % normal donkey
serum in PBS. Preparations were subsequently incubated with
primary antibodies for the adenosine A2A receptor (1:100, sc-
13937; Santa Cruz Biotechnology), adenosine A2B receptor
(1:800, AAR-003; Alomone), or cytokeratin 20 (1:100,
EPR1622Y, ab76126; Abcam) with Ezrin (1:200 to 1:400,
clone 3C12, MS-661; Lab Vision) and PECAM-1 (platelet
endothelial cell adhesion molecule-1, 1:400, sc-1506; Santa
Cruz Biotechnology) in immunoreaction enhancer solution
(Can Get Signal immunostain; Toyobo) overnight at 4 °C.
Secondary antibodies conjugated to Alexa488, Alexa568, or
Alexa647 (1:400; Molecular Probes) were added for 30 min.
In the controls, the primary antibodies were omitted and scan-
ning was performed using the same settings. Nuclei were
stained with 4′,6-diamidino-2-phenylindole (DAPI) at
1 μg/ml. Fluorescence was observed with a confocal laser
scanning microscope (LSM510 META; Carl Zeiss).
Preparation of pancreatic duct cells from guinea pig
Female Hartley guinea pigs (290–440 g, n=10) were killed by
cervical dislocation in accordance with the protocols approved
by the Animal Experimentation Committee, Kansai Medical
University. Pancreatic ducts were isolated by enzymatic diges-
tion and microdissection from the pancreas as previously de-
scribed [18, 32]. Pancreas was removed and digested with
collagenase (type IV, 124 U/ml; Worthington) and trypsin in-
hibitor (0.01 %; Sigma) in Tyrode solution at 37 °C for 1 h
with vigorous shaking. The Tyrode solution contained the
following (in mM): 140 NaCl, 0.33 NaH2PO4, 5.4 KCl, 1.8
CaCl2, 0.5 MgCl2, 5 HEPES, and 5.5 D-glucose; pH was
adjusted to 7.4 with NaOH. Interlobular and intralobular ducts
(outside diameter of 30–60 μm) were microdissected under a
stereomicroscope. The ducts were washed in Tyrode solution
and then placed on coverslips pretreated with Cell-Tak (BD
Biosciences). In order to allow patch-clamp access to the lu-
minal membranes of lining epithelial cells, the ducts were split
open by patch pipettes.
Statistics
Data are shown as means±SEM. A one-way analysis of var-
iance or Student’s paired t test was applied, and P<0.05 was
considered significant. Data were analyzed in Igor or
Microsoft Excel.
Results
Effects of luminal adenosine on transepithelial anion
secretion in Capan-1 monolayers
In order to determine whether adenosine regulated
transepithelial anion secretion in pancreatic duct cells, we
measured the electrophysiological parameters of the Capan-1
monolayer in Ussing chambers. In the present series of exper-
iments, the Capan-1 monolayer displayed a resting
transepithelial resistance (R te) of 400 ± 14 Ω cm
2,
transepithelial potential difference (Vte) of −1.14±0.05 mV,
and equivalent short-circuit current (Isc) of 2.42±0.08 μA/
cm2 (n=60). Figure 1a shows a representative original Vte
recording. The luminal addition of adenosine increased nega-
tive Vte, which indicated either transepithelial anion secretion
or cation absorption, in a concentration-dependent manner.
The EC50 value for the effects of adenosine was estimated at
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11.6± 6.5 μM with a Hill coefficient of 1.3± 0.3 (Fig. 1b;
n=4). The response to adenosine (100 μM) was relatively
reproducible in repeated applications. The response to adeno-
sine on Vte was reduced by NPPB (100 μM) or niflumic acid
(100 μM), nonselective Cl− channel blockers applied to the
luminal side (n=5; not shown). The luminal addition of the
CFTR Cl− channel inhibitor (20 μM CFTRinh-172) inhibited
the response to adenosine (Fig. 2a, b; n=5). The calculated Isc
also showed that adenosine elicited transepithelial anion se-
cretion and the response to the second stimulation with aden-
osine was inhibited by CFTRinh-172 (Fig. 2c, d). Figure 3
summarizes the effects of Cl− channel blockers on increases
in Isc (ΔIsc) stimulated by adenosine. We normalized ΔIsc
during the second stimulation in the presence of Cl− channel
blockers to ΔIsc during the first stimulation and compared
their effects. ΔIsc was not inhibited by T16Ainh-A01
(10 μM), a TMEM16A/ANO1 channel inhibitor (n=9).
Specific adenosine receptor agonists were tested to identify
functional adenosine receptors in duct cells [10]. The luminal
addition of CGS 21680 (10 μM), an adenosine A2A receptor
agonist, had a negligible effect on Isc in the Capan-1 mono-
layer: 2.01±0.28 μA/cm2 in the control and 2.10±0.30 μA/
cm2 with CGS 21680 (P=0.83, n=6; not shown). On the
other hand, BAY 60-6583 (10 μM), an adenosine A2B
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receptor agonist, increased Isc from 2.28 ± 0.27 to 3.41
± 0.19 μA/cm2, and CFTRinh-172 decreased Isc to 1.96
± 0.20 μA/cm2 (Fig. 4; n = 6). Furthermore, PSB 603
(1 μM), an adenosine A2B receptor antagonist, inhibited the
response of Isc to adenosine (Fig. 5; n=9). These results indi-
cate that the adenosine A2B receptor mediates increases in
anion transport through CFTR Cl− channels on the luminal
membranes of the Capan-1 monolayer.
Whole-cell Cl− conductance in Capan-1 single cells
with gramicidin-perforated patch methods
We confirmed the results obtained so far using patch-clamp
methods. In order to verify that adenosine activated CFTR Cl−
channels, we measured whole-cell currents in Capan-1 single
cells using gramicidin-perforated patch techniques. The appli-
cation of 100 μM adenosine increased slope conductance in a
voltage range between −103 and −63 mV from 1.03±0.19 to
2.61±0.48 nS, and this was inhibited to 1.72±0.22 nS by
20 μM CFTRinh-172 (Fig. 6a; n=8). The EC50 value for
the effects of adenosine was estimated at 9.2±5.3 μM with
a Hill coefficient of 1.1±0.2 (Fig. 6b), corresponding to the
EC50 value on Vte in Capan-1 monolayers. Consistent with the
results obtained from measurements of Isc, the application of
10 μM CGS 21680 did not significantly increase slope con-
ductance from 0.63±0.09 to 1.21±0.31 nS (P=0.14, n=6;
not shown). The application of 10 μMBAY 60-6583 induced
a sustained inward current at −83 mV, and this was reversibly
inhibited by 20 μM CFTRinh-172 (Fig. 6c; n=13). The cur-
rent response to BAY 60-6583 was observed in 68 % (13
out of 19) of the cells tested. BAY 60-6583 increased slope
conductance from 0.45 ± 0.05 to 1.49 ± 0.42 nS, and this
was inhibited to 0.58 ± 0.10 nS by CFTRinh-172 (Fig. 6d;
n= 13). When chloride was substituted with equimolar glu-
tamate in the bathing solution, the reversal potential of the
current-voltage curve shifted from −30.6 ± 2.8 to −4.5
± 9.3 mV (n = 9; not shown), indicating that membrane
conductance was chloride selective. Furthermore, the in-
ward current induced by BAY 60-6583 was also observed
in a bathing solution in which sodium was replaced with N-
methyl-D-glucamine (n= 5, not shown), suggesting that the
current through sodium-permeable cation channels was
negligible.
Immunolocalization of adenosine receptors in pancreatic
duct cells
The immunolocalization of adenosine receptors was per-
formed using Capan-1 monolayers and paraffin sections of
the rat pancreas. Immunofluorescence ascribed to the
adenosine A2A and A2B receptors was colocalized with
Ezrin, an A-kinase anchoring protein, in the luminal mem-
branes of Capan-1 monolayers (Fig. 7). Notably, the aden-
osine A2A receptors were expressed in the Capan-1 mono-
layers even though CGS 21680 had a negligible effect on
Isc. In the rat pancreas, A2A immunofluorescence was
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detected on the luminal membranes of duct cells (Fig. 8a),
as reported previously [32]. Adenosine A2A receptors
were colocalized with Ezrin in the luminal membranes
(Fig. 8b, c). Furthermore, adenosine A2B receptors were
colocalized with Ezrin in the luminal membranes of duct
cells (Fig. 8e–g). The signal for Ezrin was detected on the
luminal membranes of duct cells in which cytokeratin 20,
a duct marker [4], was expressed (Fig. 8i–k). Additionally,
the signal for adenosine A2A and A2B receptors was de-
tected on the endothelial cells of blood vessels (Fig. 8d, h).
Whole-cell Cl− conductance in pancreatic duct cells
from guinea pig
In order to demonstrate the luminal stimulatory effect of
adenosine on native pancreatic ducts, we measured whole-
cell currents in guinea pig duct cells using gramicidin-
perforated patch techniques. These ducts were split open
to allow the patch pipettes and bathing solution to access to
the luminal membranes of lining epithelial cells (Fig. 9a).
The application of 100 μM adenosine significantly
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increased slope conductance in a voltage range between
−103 and −63 mV from 2.25 ± 0.57 to 3.72 ± 0.63 nS
(Fig. 9b; n= 13). Adenosine induced a sustained inward
Cl− current at −83 mV in a concentration-dependent man-
ner (Fig. 9c). The concentration-response curve was fitted
with a Hill equation and the EC50 value was 21.2
± 11.7 μM with a Hill coefficient of 1.0 ± 0.3 (Fig. 9d;
n= 5). Recent studies have shown that ethanol affects the
function of CFTR Cl− channels in pancreatic epithelial
cells [23]. The application of ethanol did not show signif-
icant effects on the adenosine-stimulated conductance in a
voltage range between −103 and −63 mV from 2.49 ± 0.30
to 2.85 ± 0.30 at 1 mM and 3.08 ± 0.35 nS at 10 mM within
2 min in guinea pig duct cells (P= 0.34 and 0.20, respec-
tively, n= 7; not shown).
Discussion
In the present study, we demonstrated that the luminal
adenosine A2B receptor regulated the CFTR Cl
− channels
necessary for anion secretion in Capan-1 cells. This con-
clusion was based on the following major results: the lu-
minal addition of adenosine elicited transepithelial anion
transport through CFTR Cl− channels in Capan-1 mono-
layers; the adenosine A2B receptor agonist activated anion
transport; the adenosine response was inhibited by the
adenosine A2B receptor antagonist; the adenosine A2B re-
ceptor agonist activated CFTR Cl− channels in Capan-1
single cells; the adenosine A2B receptors colocalized with
Ezrin in the luminal membranes of Capan-1 monolayers
and rat pancreatic ducts; and adenosine elicited the
whole-cell Cl− currents in pancreatic duct cells from guin-
ea pig.
Adenosine A2B receptors primarily signal via Gs proteins,
resulting in the activation of adenylyl cyclase, an increase in
cAMP production, activation of a membrane-associated iso-
form of protein kinase A (type II PKA), and subsequent acti-
vation of CFTRCl− channels [5, 21, 41]. Since adenosine A2B
receptors were found to colocalize with Ezrin, an A-kinase
anchoring protein, in the luminal membranes of duct cells
(Figs. 7 and 8), Ezrin may scaffold type II PKA and compo-
nents of cAMP signaling pathways, including the adenosine
A2B receptor, adenylyl cyclase, and CFTR Cl
− channels [8,
12, 20, 27]. Previous studies reported that Ezrin physically
interacted with type II PKA and adenosine A2B receptors in
intestinal epithelial cells [37]. Ezrin was also shown to asso-
ciate with CFTR Cl− channels by NHERF1 (also called
Fig. 7 Immunolocalization of adenosine A2A (a–e) and A2B (f–j)
receptors with Ezrin staining in Capan-1 monolayers. Fluorescence
images of adenosine A2A receptors on the basolateral (a) and luminal
(b) membranes in the Capan-1 monolayer. c Z-scan image of the same
sample in a and b. d Fluorescence image of Ezrin. e Overlay image of c
and d. Broken lines indicate the position of the permeable membrane.
Fluorescence images of adenosine A2B receptors on the basolateral (f)
and luminal (g) membranes in the Capan-1 monolayer. Z-scan images
of adenosine A2B receptors (h), Ezrin (i), and overlay (j). DAPI was used
to stain nuclei (blue). Bars= 20 μm
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EBP50) or NHERF2 (E3KARP) in airway epithelial cells [36,
43]. CFTR Cl− channels and NHERF1/EBP50 were found to
colocalize in the luminal regions of mouse pancreatic duct
cells [2]. Moreover, the adenosine A2B receptor physically
interacted with NHERF1 in a mammalian expression system
or with NHERF2 in intestinal epithelial cells [30, 37].
Furthermore, adenosine A2B receptors interacted with CFTR
Cl− channels, which influenced the number of adenosine A2B
receptors in the plasma membrane [48]. A recent study report-
ed that pancreatic ducts expressed multiple adenylyl cyclase
(AC) isoforms: AC3, AC4, AC6, AC7, and AC9 [35]. Further
studies are required to clarify whether Ezrin associates with
adenylyl cyclase isoforms and accomplishes the compartmen-
talization of cAMP signaling in the luminal regions of pancre-
atic duct cells.
In accordance with the present results, previous studies
demonstrated that adenosine A2B receptors regulated Cl
−
channels in various secretory epithelia, including airway
epithelia [20], the colon [3, 42], duodenum [17], renal in-
ner medullary collecting duct [34], middle ear epithelia
[13], and CFTR-transfected CFPAC-1 cell line [33]. In
addition to epithelial transport, the adenosine A2B receptor
is known to be involved in inflammation and immunity in
the vascular system [9]. We found that adenosine A2A and
A2B receptors were also expressed in the endothelial cells
of blood vessels in the pancreas (Fig. 8d, h), which implied
that these receptors may regulate blood pressure and the
vascular flow rate in the pancreas [14, 51]. Furthermore,
the activation of adenosine A2B receptors was shown to
promote the growth and metastasis of cancer [28, 40, 49].
Therefore, adenosine A2B receptors may be a potential tar-
get for pancreatic cancer therapy as well as dysfunctions in
epithelial transport.
Extracellular adenosine concentrations are generally
considered to be less than 1 μM in unstressed tissues,
whereas they may markedly increase during ischemia or
Fig. 8 Immunolocalization of adenosine receptors in the rat pancreas. a
Fluorescence of adenosine A2A receptors on the luminal membranes of
duct cells. The duct is indicated by broken lines. b Fluorescence image of
Ezrin. cOverlay image of a and b. dOverlay of a and fluorescence image
of a blood vessel marker (purple: PECAM-1) in the same sample.
Arrowhead shows a blood vessel. e Fluorescence of adenosine A2B
receptors on the luminal membranes of a duct (broken lines).
Fluorescence images of Ezrin (f) and overlay (g). h The overlay image
shows the green fluorescence of adenosine A2B receptors on a blood
vessel (arrowhead). Fluorescence images of cytokeratin 20 (i), Ezrin
(j), and overlay (k). l Control image of the rat pancreas, in which
primary antibodies were omitted. The broken line indicates a duct.
DAPI was used to stain nuclei (blue). Bars= 20 μm
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inflammation [1]. Our results showed that adenosine acti-
vated anion secretion and Cl− channels with Kd values of
approximately 10 μM in Capan-1 cells (Figs. 1 and 6b) as
well as Cl− channels with a Kd value of 20 μM in guinea
pig duct cells (Fig. 9d), corresponding approximately to
the Kd value of 15 μM on the adenosine A2B receptor
[10]. In the lumen of pancreatic ducts, adenosine is pro-
duced by the hydrolysis of ATP, which acini release at 10–
20 μM [38, 39, 52]. Capan-1 monolayers have also been
shown to release ATP, which stimulates purinergic recep-
tors on the luminal membrane [24]. In addition, the extra-
cellular concentration of adenosine in supernatant collect-
ed from Capan-1 cells was 2.5 μM at basal levels [25].
Therefore, adenosine may reach high concentrations in
the ductal lumen and affect adenosine A2B receptors on
the luminal membrane. However, we cannot rule out the
contribution of adenosine A2A receptors to transepithelial
anion secretion and the activation of Cl− channels in
Capan-1 cells. Importantly, adenosine A2A receptor had
higher mRNA level than A2B receptor did in rat pancreas.
In addition, the strongest immunofluorescence ascribed to
the adenosine A2A receptor was detected on the luminal
membrane of rat ducts [32]. A previous study proposed
that adenosine A2A receptors formed a functional hetero-
oligomer complex with adenosine A2B receptors and were
involved in their surface expression [29]. Future studies are
needed in order to establish the presence of the hetero-
oligomer in the luminal membranes of pancreatic duct cells
and the functional relevance it may have.
Electrophysiological studies on native pancreatic ductal
epithelial cells have shown that 10 mM ethanol increased
basal but blocked forskolin-stimulated CFTR currents
[23]. We predicted that ethanol would affect the adenosine
signaling and activity of Cl− channels. However, ethanol
(1 and 10 mM) had no effect on adenosine-stimulated
conductance with gramicidin-perforated patch-clamp in
guinea pig duct cells. A recent study has shown that ap-
plication of ethanol had negligible effects on ATP release
from Capan-1 cells [25].
In conclusion, we showed that adenosine regulated anion
secretion by activating CFTR Cl− channels via adenosine A2B
receptors on the luminal membranes of Capan-1 cells.
Luminal adenosine may be another important coordinator
for acini-to-duct signaling, and by virtue of supporting ductal
secretion, it may help to flush out digestive enzymes delivered
from acini.
Fig. 9 Effects of adenosine on the whole-cell current in pancreatic duct
cell from guinea pig. a An isolated interlobular duct of the guinea pig
pancreas. The duct, which has an outside diameter of about 50μm, is split
open to allow patch-clamp access to the luminal membranes of lining
epithelial cells. The duct is held by the pipette on the left side.
Bar = 50 μm. b Representative current-voltage relationships for the
whole-cell current. The current was elicited by a voltage ramp from
−123 to +37 mV with a rate of 0.2 V/s. Adenosine (Ado; 100 μM)
increased the current in the NaCl-rich bathing solution (c). c The
representative trace demonstrates the increase observed in the inward
current at −83 mV in response to adenosine (0.1–1000 μM) in a
concentration-dependent manner. d Concentration-response curve for
adenosine at −83 mV. The solid line is the fit by the Hill equation (n= 5)
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